Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - dimethylfumarat - enterokapsler, hårde - 120 mg

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

hexal a/s - dimethylfumarat - enterokapsler, hårde - 120 mg

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

rotterdam biologics b.v. - bevacizumab - wet macular degeneration - oftalmologiske - treatment of neovascular (wet) age-related macular degeneration (amd).

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

astellas pharma europe bv - tacrolimus - graft afvisning - immunosuppressiva - profylakse af transplantationsafstødning hos voksne nyre- eller levertransplantationsmodtagere. behandling af allograft afvisning resistente over for behandling med andre immunosuppressive lægemidler hos voksne patienter.

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a. - tacrolimus - graft afvisning - immunosuppressiva - profylakse af transplantationsafstødning hos voksne nyre- eller levertransplantationsmodtagere. behandling af allograft afvisning resistente over for behandling med andre immunosuppressive lægemidler hos voksne patienter.

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

astellas pharma europe b.v. - tacrolimus - graft afvisning - immunosuppressiva - profylakse af transplantatafstødning hos voksne og pædiatriske, nyre-, lever- eller hjerte-allograftmodtagere. behandling af allograft rejection resistente over for behandling med andre immunsuppressive lægemidler hos voksne og pædiatriske patienter.

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - tacrolimusmonohydrat - kapsler, hårde - 0,75 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - tacrolimusmonohydrat - kapsler, hårde - 1 mg